Real-time enrollment status for this small cell lung carcinoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 2:51 PM UTC
| NCT Number | NCT07006727 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 116 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | July 28, 2026 (Jul 28, 2026) |
As of August 31, 2026: Clinical trial NCT07006727 is currently recruiting participants. This phase1 study for small cell lung carcinoma is actively seeking new participants at 4 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07006727 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07006727 was last updated Jul 28, 2026 (July 28, 2026). HelloStudys verifies this status automatically.